Aspiriant LLC’s Forty Seven, Inc. Common Stock FTSV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,131
Closed -$299K 200
2020
Q1
$299K Buy
+3,131
New +$189K 0.03% 157

Other funds holding FTSV

Aspiriant LLC's FTSV Position: Q2 2020 in Review

Aspiriant LLC sold out of Forty Seven, Inc. Common Stock (FTSV) in Q2 2020, closing a stake of 3,131 shares — an estimated $299K sold.

Aspiriant LLC first reported a position in FTSV in Q1 2020 and held it in 1 quarter. The position peaked at $299K in Q1 2020. 1 fund tracked by Wall St. Rank holds FTSV as of Q2 2020.

  • Aspiriant LLC reported no remaining Forty Seven, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Aspiriant LLC sold 3,131 Forty Seven, Inc. Common Stock shares in Q2 2020, an estimated $299K.
  • Aspiriant LLC first reported a position in Forty Seven, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Aspiriant LLC's Forty Seven, Inc. Common Stock position peaked at $299K in Q1 2020.
  • 1 fund tracked by Wall St. Rank held Forty Seven, Inc. Common Stock as of Q2 2020.

Based on Aspiriant LLC's 13F filing for Q2 2020, filed 6 Aug 2020.